Abstract
The capacity of a new drug containing ultra-low doses of antibodies to cannabinoid receptor type 1 (Dietressa) to reduce body weight gain in mice on a high-calorie diet was evaluated, possible mechanisms of drug action were analyzed, and its safety (abuse potential in the reaction of self-stimulation) was evaluated. Dietressa was not inferior to sibutramine in reducing body weight gain in mice and exhibited no abuse potential.
Links
Authors
Kheyfets IA, Bugaeva LI, Vorob'eva TM, Dugina JL, Lebedeva SA, Petrov VI, Sergeeva SA, Epstein OI
Institution
Materia Medica Holding, Moscow, Russia. nauka@materiamedica.ru
Source
Bulletin of experimental biology and medicine 152:3 2012 Jan pg 321-4Pub Type(s)
Journal ArticleLanguage
eng
PubMed ID
22803076
Log In

